Yan Z X, Meyer T F
Abteilung Infektionsbiologie, Max-Planck-Institut für Biologie, Tübingen, Germany.
J Biotechnol. 1996 Jan 26;44(1-3):197-201. doi: 10.1016/0168-1656(95)00116-6.
Attenuated strains of enteropathogenic species, such as Salmonella, represent useful carries for the delivery of heterologous recombinant antigens to the immune system. A frequently encountered obstacle, however, is the negative influence of high-level antigen production on the stability of carrier strains and the maintenance of their specific properties concerning tissue colonization and viability during infection. To solve this problem we have established an expression system based on genetic variation. This generates two sub-populations of a recombinant vaccine strain, i.e., one consisting of viable cells which maintain all characteristics of the native carrier strain and generate a second population of cells producing antigen(s) of interest at a very high level. This novel expression system offers unique applications and advantages over common live recombinant vaccine approaches.
减毒的肠道致病物种菌株,如沙门氏菌,是将异源重组抗原递送至免疫系统的有用载体。然而,一个经常遇到的障碍是高水平抗原产生对载体菌株稳定性以及其在感染期间关于组织定植和生存能力的特定特性维持的负面影响。为了解决这个问题,我们建立了一种基于基因变异的表达系统。这产生了重组疫苗菌株的两个亚群,即一个由维持天然载体菌株所有特征的活细胞组成,另一个由高水平产生感兴趣抗原的细胞群体组成。这种新型表达系统相对于常见的活重组疫苗方法具有独特的应用和优势。